Tapewire

Nasdaq · USD

GT

GOODYEAR TIRE & RUBBER CO /OH/

Export transactions ↓
Tapewire entity
753
SEC CIK
0000042582
Parsed reports
772

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 25, 2023 Filed Jul 27, 2023 14:39 UTC GrantRestricted Stock Units · Derivative 7,321 $15.49 $113,402.29
Disclosure

SEC source: 0001209191-23-043468 · doc4.xml · derivative · entry 1

Hinrichs Joseph R · CIK 0001422651 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,321

Underlying: Common Stock · 7,321 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 19:54 UTC GrantRestricted Stock Units · Derivative 592 $13.72 $8,122.24
Disclosure

SEC source: 0001209191-23-040927 · doc4.xml · derivative · entry 1

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,593

Underlying: Common Stock · 592 shares

Expires not disclosed

F1 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Company's Outside Directors' Equity Participation Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 19:53 UTC GrantRestricted Stock Units · Derivative 1,184 $13.72 $16,244.48
Disclosure

SEC source: 0001209191-23-040925 · doc4.xml · derivative · entry 1

CLAYTON NORMA · CIK 0001877468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,267

Underlying: Common Stock · 1,184 shares

Expires not disclosed

F1 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Company's Outside Directors' Equity Participation Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement.

Read SEC document
May 05, 2023 Filed May 9, 2023 20:09 UTC
Zamarro Christina LEVP & Chief Financial Officer
Exercise / conversion2017 Plan Restricted Stock Units · Derivative 16,612 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028238 · doc4.xml · derivative · entry 4

Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020.

F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020.

F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted May 5, 2020.

Read SEC document
May 05, 2023 Filed May 9, 2023 20:09 UTC
Zamarro Christina LEVP & Chief Financial Officer
Tax withholdingCommon Stock 5,042 $11.43 $57,630.06
Disclosure

SEC source: 0001209191-23-028238 · doc4.xml · nonDerivative · entry 2

Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,272

F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes.

Read SEC document
May 05, 2023 Filed May 9, 2023 20:09 UTC
Zamarro Christina LEVP & Chief Financial Officer
Exercise / conversionCommon Stock 16,612 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028238 · doc4.xml · nonDerivative · entry 1

Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:38 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024099 · doc4.xml · derivative · entry 1

Williams Thomas L · CIK 0001320730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,750

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:36 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024096 · doc4.xml · derivative · entry 1

Wessel Michael · CIK 0001346244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,492

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:35 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024095 · doc4.xml · derivative · entry 1

PALMORE RODERICK A · CIK 0001218964 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,443

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:32 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024094 · doc4.xml · derivative · entry 1

MCGLADE JOHN E · CIK 0001265896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,211

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:30 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024093 · doc4.xml · derivative · entry 1

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,244

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:29 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024092 · doc4.xml · derivative · entry 1

Lewis Karla R · CIK 0001256541 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,616

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:25 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024091 · doc4.xml · derivative · entry 1

KOELLNER LAURETTE T · CIK 0001182054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,505

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:24 UTC
Siu Hera KDirector
GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024089 · doc4.xml · derivative · entry 1

Siu Hera K · CIK 0001796462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,198

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:22 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024083 · doc4.xml · derivative · entry 1

Geissler Werner · CIK 0001402226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,402

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:19 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024077 · doc4.xml · derivative · entry 1

FIRESTONE JAMES A · CIK 0001207838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,492

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:17 UTC GrantRestricted Stock Units · Derivative 15,139 $10.83 $163,955.37
Disclosure

SEC source: 0001209191-23-024075 · doc4.xml · derivative · entry 1

CLAYTON NORMA · CIK 0001877468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,253

Underlying: Common Stock · 15,139 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:02 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023250 · doc4.xml · derivative · entry 1

Williams Thomas L · CIK 0001320730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,611

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:00 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023246 · doc4.xml · derivative · entry 1

Wessel Michael · CIK 0001346244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,353

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:58 UTC
Siu Hera KDirector
GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023245 · doc4.xml · derivative · entry 1

Siu Hera K · CIK 0001796462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,059

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:54 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023243 · doc4.xml · derivative · entry 1

MCGLADE JOHN E · CIK 0001265896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,072

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:56 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023244 · doc4.xml · derivative · entry 1

PALMORE RODERICK A · CIK 0001218964 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,304

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:53 UTC GrantRestricted Stock Units · Derivative 744 $10.92 $8,124.48
Disclosure

SEC source: 0001209191-23-023242 · doc4.xml · derivative · entry 2

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,001

Underlying: Common Stock · 744 shares

Expires not disclosed

F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:53 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023242 · doc4.xml · derivative · entry 1

Mahendra-Rajah Prashanth · CIK 0001609983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,105

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:51 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023239 · doc4.xml · derivative · entry 1

Lewis Karla R · CIK 0001256541 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,477

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:49 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023238 · doc4.xml · derivative · entry 1

KOELLNER LAURETTE T · CIK 0001182054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,365

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:47 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023237 · doc4.xml · derivative · entry 1

Geissler Werner · CIK 0001402226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,263

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:45 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023236 · doc4.xml · derivative · entry 1

FIRESTONE JAMES A · CIK 0001207838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,353

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:44 UTC GrantRestricted Stock Units · Derivative 1,488 $10.92 $16,248.96
Disclosure

SEC source: 0001209191-23-023235 · doc4.xml · derivative · entry 2

CLAYTON NORMA · CIK 0001877468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,083

Underlying: Common Stock · 1,488 shares

Expires not disclosed

F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 19:44 UTC GrantRestricted Stock Units · Derivative 3,663 $10.92 $39,999.96
Disclosure

SEC source: 0001209191-23-023235 · doc4.xml · derivative · entry 1

CLAYTON NORMA · CIK 0001877468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,114

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan.

F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service.

F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 14:33 UTC
Snyder Margaret VVice President and Controller
Grant2022 Plan Restricted Stock Units · Derivative 6,805 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022502 · doc4.xml · derivative · entry 2

Snyder Margaret V · CIK 0001971622 · Vice President and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,805

Underlying: Common Stock · 6,805 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on March 31, 2026.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 14:33 UTC
Snyder Margaret VVice President and Controller
Grant2022 Plan Performance Share Units · Derivative 4,537 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022502 · doc4.xml · derivative · entry 1

Snyder Margaret V · CIK 0001971622 · Vice President and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,537

Underlying: Common Stock · 4,537 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:52 UTC
Zamarro Christina LEVP & Chief Financial Officer
Grant2022 Plan Restricted Stock Units · Derivative 59,158 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014172 · doc4.xml · derivative · entry 2

Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,158

Underlying: Common Stock · 59,158 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:52 UTC
Zamarro Christina LEVP & Chief Financial Officer
Grant2022 Plan Performance Units · Derivative 39,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014172 · doc4.xml · derivative · entry 1

Zamarro Christina L · CIK 0001934429 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,439

Underlying: Common Stock · 39,439 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:51 UTC
WELLS DARREN REVP & Chief Admin. Officer
Grant2022 Plan Restricted Stock Units · Derivative 84,136 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014164 · doc4.xml · derivative · entry 2

WELLS DARREN R · CIK 0001190977 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,136

Underlying: Common Stock · 84,136 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:51 UTC
WELLS DARREN REVP & Chief Admin. Officer
Grant2022 Plan Performance Share Units · Derivative 56,091 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014164 · doc4.xml · derivative · entry 1

WELLS DARREN R · CIK 0001190977 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,091

Underlying: Common Stock · 56,091 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:49 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Grant2022 Plan Restricted Stock Units · Derivative 34,180 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014159 · doc4.xml · derivative · entry 2

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,180

Underlying: Common Stock · 34,180 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:49 UTC
VanderLind GarySR VP & Chief Human Res. Ofcr.
Grant2022 Plan Performance Units · Derivative 22,787 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014159 · doc4.xml · derivative · entry 1

VanderLind Gary · CIK 0001765321 · SR VP & Chief Human Res. Ofcr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,787

Underlying: Common Stock · 22,787 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:47 UTC
Scocos Evan MVice President and Controller
Grant2022 Plan Restricted Stock Units · Derivative 13,146 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014156 · doc4.xml · derivative · entry 2

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,146

Underlying: Common Stock · 13,146 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:47 UTC
Scocos Evan MVice President and Controller
Grant2022 Plan Performance Units · Derivative 8,764 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014156 · doc4.xml · derivative · entry 1

Scocos Evan M · CIK 0001674989 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,764

Underlying: Common Stock · 8,764 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:46 UTC
Phillips David EmmittSr VP and General Counsel
Grant2022 Plan Restricted Stock Units · Derivative 39,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014153 · doc4.xml · derivative · entry 2

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,439

Underlying: Common Stock · 39,439 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:46 UTC
Phillips David EmmittSr VP and General Counsel
Grant2022 Plan Performance Units · Derivative 26,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014153 · doc4.xml · derivative · entry 1

Phillips David Emmitt · CIK 0001777552 · Sr VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,292

Underlying: Common Stock · 26,292 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:43 UTC
McClellan Stephen RPresident, Americas
Grant2022 Plan Restricted Stock Units · Derivative 76,248 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014150 · doc4.xml · derivative · entry 2

McClellan Stephen R · CIK 0001447779 · President, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,248

Underlying: Common Stock · 76,248 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:43 UTC
McClellan Stephen RPresident, Americas
Grant2022 Plan Performance Units · Derivative 50,832 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014150 · doc4.xml · derivative · entry 1

McClellan Stephen R · CIK 0001447779 · President, Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,832

Underlying: Common Stock · 50,832 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:41 UTC
Madarang NathanielPresident, Asia Pacific
Grant2022 Plan Restricted Stock Units · Derivative 28,921 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014146 · doc4.xml · derivative · entry 2

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,921

Underlying: Common Stock · 28,921 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:41 UTC
Madarang NathanielPresident, Asia Pacific
Grant2022 Plan Performance Units · Derivative 19,281 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014146 · doc4.xml · derivative · entry 1

Madarang Nathaniel · CIK 0001850599 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,281

Underlying: Common Stock · 19,281 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:39 UTC
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
Grant2022 Plan Restricted Stock Units · Derivative 280,017 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014142 · doc4.xml · derivative · entry 2

KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,017

Underlying: Common Stock · 280,017 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:39 UTC
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
Grant2022 Plan Performance Units · Derivative 186,678 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014142 · doc4.xml · derivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,678

Underlying: Common Stock · 186,678 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:38 UTC
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
Grant2022 Plan Restricted Stock Units · Derivative 37,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014139 · doc4.xml · derivative · entry 2

Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,467

Underlying: Common Stock · 37,467 shares

Expires not disclosed

F2 · security: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 27, 2026.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:38 UTC
Helsel Christopher PSr VP Glbl Ops Chief Tech Ofcr
Grant2022 Plan Performance Units · Derivative 24,978 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014139 · doc4.xml · derivative · entry 1

Helsel Christopher P · CIK 0001763728 · Sr VP Glbl Ops Chief Tech Ofcr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,978

Underlying: Common Stock · 24,978 shares

Expires not disclosed

F1 · security: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_price: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.exercise_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

F1 · derivative.expiration_date: Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2026. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2025, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.